MedPath

Assessment of PPG & PAT to Detect Upper Airway Obstruction in Patients With Obstructive Sleep Apnea

Not Applicable
Conditions
Sleep Apnea, Obstructive
Registration Number
NCT01831583
Lead Sponsor
Sotera Wireless, Inc.
Brief Summary

The goal of this study is to collect raw waveform data for two separate noninvasive methods, both of which may be useful for the assessment of upper airway obstruction.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients twenty-one years of age or older
Exclusion Criteria
  • Patient refusal to participate in study
  • Patients under 21 (twenty-one) years of age,
  • Referring physician's refusal to have his/her patient participate in the study.
  • Patients with cardiac dysrhythmia (arrhythmia), including atrial fibrillation, and frequent premature atrial and/or ventricular contractions.
  • Inability to obtain a Sotera cuff pressure and/or PPG signals

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Measurement of pulse arrival time in patients with obstructive sleep apnea syndrome.4 - 8 hours

The goal of this study is to collect pulse arrival time data as a means for the assessment of upper airway obstruction.

Secondary Outcome Measures
NameTimeMethod
Non-invasive Photoplethysmographic (PPG) measurement in patients with obstructive sleep apnea syndrome.4 - 8 hours

The goal of this study is to collect PPG waveforms as a means for the assessment of upper airway obstruction.

Trial Locations

Locations (1)

Palomar Hospital

🇺🇸

Escondido, California, United States

Palomar Hospital
🇺🇸Escondido, California, United States
Anoop Karippot, M.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.